Bright Eye Hospital Group Co., Ltd.

SZSE:301239 Stock Report

Market Cap: CN¥5.4b

Bright Eye Hospital Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Qiang Sun

Chief executive officer

CN¥949.7k

Total compensation

CEO salary percentagen/a
CEO tenure3.1yrs
CEO ownershipn/a
Management average tenure7.7yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Chengdu Bright Eye Hospital Group (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Mar 10
Chengdu Bright Eye Hospital Group (SZSE:301239) Is Reinvesting At Lower Rates Of Return

With A 28% Price Drop For Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) You'll Still Get What You Pay For

Jan 08
With A 28% Price Drop For Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) You'll Still Get What You Pay For

These 4 Measures Indicate That Chengdu Bright Eye Hospital Group (SZSE:301239) Is Using Debt Extensively

Dec 17
These 4 Measures Indicate That Chengdu Bright Eye Hospital Group (SZSE:301239) Is Using Debt Extensively

After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Nov 19
After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Chengdu Bright Eye Hospital (SZSE:301239) Seems To Use Debt Quite Sensibly

Aug 15
Chengdu Bright Eye Hospital (SZSE:301239) Seems To Use Debt Quite Sensibly

Chengdu Bright Eye Hospital's (SZSE:301239) Upcoming Dividend Will Be Larger Than Last Year's

Jul 19
Chengdu Bright Eye Hospital's (SZSE:301239) Upcoming Dividend Will Be Larger Than Last Year's

Chengdu Bright Eye Hospital (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Jul 18
Chengdu Bright Eye Hospital (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Paint A Concerning Picture

Apr 11
Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Paint A Concerning Picture

CEO

Qiang Sun (44 yo)

3.1yrs
Tenure
CN¥949,700
Compensation

Mr. Qiang Sun is General Manager & Non-Independent Director of Chengdu Bright Eye Hospital Group Co., Ltd. (formerly known as Chengdu Bright Eye Hospital Co., Ltd.) from October 10, 2022.

Leadership Team

NamePositionTenureCompensationOwnership
Qiang Sun
GM & Non-Independent Director3.1yrsCN¥949.70kno data
Guo Ping Yang
Chief Financial Officer9.2yrsCN¥660.70kno data
Changliang Cao
Deputy GM & Non-Independent Directorno dataCN¥852.60kno data
Liang Jin
Deputy GM & Company Secretary7.7yrsCN¥1.02mno data
7.7yrs
Average Tenure
44.5yo
Average Age

Experienced Management: 301239's management team is seasoned and experienced (7.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Qiang Sun
GM & Non-Independent Director3.1yrsCN¥949.70kno data
Changliang Cao
Deputy GM & Non-Independent Director9.2yrsCN¥852.60kno data
Penghui Chen
Independent Director6.2yrsCN¥60.00kno data
Xuyang Xu
Chairman of the Board9.2yrsCN¥610.60k42.88%
CN¥ 2.3b
Huadong Tang
Independent Director3.1yrsCN¥60.00kno data
Quanfang Hu
Non-Employee Supervisor3.1yrsno datano data
Di Nan
Non-Employee Supervisor3.1yrsno datano data
Xiaocong Xiong
Non-Independent Director6.9yrsno datano data
Ping Hou
Non-Independent Directorno datano datano data
3.1yrs
Average Tenure
52.5yo
Average Age

Experienced Board: 301239's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/20 20:42
End of Day Share Price 2025/11/20 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bright Eye Hospital Group Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiaqi XuCitic Securities Co., Ltd.